Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.44 |
| ▸ | ADH1A | P07327 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
| ▸ | ADH7 | P40394 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecanol SCHEMBL8386490 | 1.00 | TSHR (0.62) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Decanol SCHEMBL21530620 | 1.00 | TSHR (0.62) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Tridecanal SCHEMBL10451602 | 0.91 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Heptanal SCHEMBL2635440 | 0.91 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Decanol SCHEMBL27552108 | 0.91 | TSHR (0.68) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Hexanal SCHEMBL2635617 | 0.91 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Hexanal SCHEMBL5504335 | 0.91 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Octanal SCHEMBL6061355 | 0.91 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Dodecanol SCHEMBL8387775 | 0.91 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Hexanal SCHEMBL28743151 | 0.91 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190002486-A1 | PROCESSES FOR PRODUCING ORGANOPHOSPHOROUS COMPOUNDS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2019-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190002486-A1 | PROCESSES FOR PRODUCING ORGANOPHOSPHOROUS COMPOUNDS | IPMK, PHOSPHO1, MTAP | TSHR 3616/4885ALDH1A1 3924/4885LMNA 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.